Why the study?
Does fenofibrate reduce cardiac fibrosis and endothelin-1 production in pressure-overloaded rat hearts?
Population
Rats with hypertrophied hearts due to pressure-overload by abdominal aortic banding (AB)
Comparison
Fenofibrate started 7 days before abdominal… vs Vehicle treatment
Design
Preclinical
Follow-up
4 days after abdominal aortic banding
Authors
Loading...
Hypothesis-generating for fenofibrate in pressure-overload fibrosis; leaves open human translation and clinical relevance.
Does fenofibrate reduce cardiac fibrosis and endothelin-1 production in pressure-overloaded rat hearts?
Fenofibrate attenuates myocardial fibrosis and ET-1 production in pressure-overloaded rat hearts, likely through suppression of AP-1-mediated ET-1 gene augmentation.
Ogata et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: